INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
06/10/2026
Back to search
Official data from USPTO
EXIAS MEDICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EXIAS MEDICAL
ST13
US500000079239936Class
5, 9, 10, 42
Filing
79239936
Registration
5706355
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
06/11/2026
Trademark type
Word
Nice classes
5, 9, 10, 42
Filing date
05/07/2018
Registration date
03/26/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/10/2025
Last transaction
06/11/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
27
Owner location
AT
Examiner
CIANCI, RYAN MICHAEL
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
EXIAS Medical GmbH
Representatives
EXIAS Medical GmbH
Technical classification
Nice Classes
Class 5Class 9Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
In vitro diagnostic reagents for medical purposes; diagnostic agents for medical and veterinary purposes
Class 9
Software for remote control of diagnostic testing apparatus
Class 10
Surgicalmedicaldental and veterinary apparatus and instrumentsin particular apparatus for in vitroex vivo and in vivo diagnostics in the intensive care; diagnostic apparatus for measuring critical care parameters for medical purposes; testing apparatus for measuring critical care parameters for medical purposes; mobile diagnostic and testing apparatus for measuring critical care parameters for medical purposes
Class 42
Development services in the field of diagnostic agents; design and development of diagnostic apparatus for medical and veterinary purposes
Publications
History of USPTO decisions and trademark events.
22 publications found
C71T
CANCELLED SECTION 71
10/10/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/16/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/30/2019
FIMP
FINAL DISPOSITION PROCESSED
07/30/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/26/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
03/26/2019
PUBO
PUBLISHED FOR OPPOSITION
01/08/2019
NPUB
NOTICE OF PUBLICATION
12/19/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/23/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/21/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/21/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/21/2018
RFNT
REFUSAL PROCESSED BY IB
10/13/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/21/2018
RFRR
REFUSAL PROCESSED BY MPU
09/21/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/19/2018
CNRT
NON-FINAL ACTION WRITTEN
09/18/2018
MAFR
APPLICATION FILING RECEIPT MAILED
09/18/2018
DOCK
ASSIGNED TO EXAMINER
09/12/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/12/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/06/2018
Continuous trademark protection
Get notified about every new filing that threatens EXIAS MEDICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.